Larry Biegelsen
Stock Analyst at Wells Fargo
(4.71)
Main Sectors:
36 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | Upgrades: Overweight | 170 212 | 188.64 | 12.38% | 14 | Oct 3, 2025 | |
COO Cooper Companies | Maintains: Overweight | 93 72 | 70.46 | 2.19% | 18 | Aug 28, 2025 | |
MDT Medtronic | Maintains: Overweight | 98 100 | 97.7 | 2.35% | 18 | Aug 20, 2025 | |
HYPR Hyperfine | Maintains: Equal-Weight | 1 1 | 1.48 | -42.57% | 6 | Aug 15, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Equal-Weight | 20 13 | 14.71 | -11.62% | 10 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 88 | 77.07 | 14.18% | 17 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Equal-Weight | 93 | 77.39 | 20.17% | 9 | Aug 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 174 101 | 76.64 | 31.78% | 13 | Aug 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 435 445 | 370.6 | 20.08% | 15 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 137 131 | 130.94 | 0.05% | 6 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 3 | 1.84 | 63.04% | 7 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 33 24 | 23.86 | 0.59% | 17 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 86 92 | 87.39 | 5.28% | 15 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 15 | 15.2 | -1.32% | 7 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 108 100 | 84.21 | 18.75% | 11 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 315 290 | 256 | 13.28% | 19 | Jul 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 40 15 | 14.66 | -1.09% | 18 | Jul 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 118 124 | 97.31 | 27.43% | 13 | Jul 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 559 599 | 452.35 | 32.42% | 20 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 27 | 24.82 | 8.78% | 2 | Jul 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 25 9 | 8.8 | 2.27% | 14 | Jul 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 113 98 | 100.78 | -2.76% | 10 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 89 | 76.56 | 16.25% | 4 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 10.92 | 55.68% | 1 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 65 80 | n/a | n/a | 6 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 94 | 67.05 | 40.19% | 9 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 14 | n/a | n/a | 11 | Apr 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 200 210 | n/a | n/a | 6 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 68 71 | n/a | n/a | 6 | Jan 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 40 49 | 14.8 | 231.08% | 2 | Dec 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 136 | 134.58 | 1.06% | 21 | Apr 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 60.48 | 15.74% | 7 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 62 | n/a | n/a | 6 | May 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 279 270 | 193.58 | 39.48% | 5 | Apr 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 2, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Apr 25, 2017 |